Lite Strategy, Inc. Research and Development Expense
Lite Strategy, Inc. (LITS) reported Research and Development Expense of $30.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-05-13
- Lite Strategy, Inc. research and development expense for the quarter ending 2026-03-31 was $30.00K, a 91.87% decline year-over-year.
- Lite Strategy, Inc. research and development expense for the quarter ending 2025-12-31 was $46.00K, a 85.06% decline year-over-year.
- Lite Strategy, Inc. research and development expense for the quarter ending 2025-09-30 was $10.00K, a 99.68% decline year-over-year.
- Lite Strategy, Inc. research and development expense for the quarter ending 2025-06-30 was $83.00K, a 97.90% decline year-over-year.
- Lite Strategy, Inc. research and development expense for fiscal 2025 was $3.92M, a 76.31% decline from fiscal 2024.
- Lite Strategy, Inc. research and development expense for fiscal 2024 was $16.56M, a 68.43% decline from fiscal 2023.
- Lite Strategy, Inc. research and development expense for fiscal 2023 was $52.45M, a 38.76% decline from fiscal 2022.
- Lite Strategy, Inc. research and development expense for fiscal 2022 was $85.64M, a 23.41% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month | Research and Development Expense 130 month | Research and Development Expense 133 month | Research and Development Expense 136 month | Research and Development Expense 139 month | Research and Development Expense 142 month | Research and Development Expense 145 month | Research and Development Expense 148 month | Research and Development Expense 151 month | Research and Development Expense 154 month | Research and Development Expense 157 month | Research and Development Expense 160 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $30.00K 10-Q · filed 2026-05-13 | $76.00K derived: sum of 2 quarters · filed 2026-05-13 | $86.00K 10-Q · filed 2026-05-13 | $169.00K derived: sum of 4 quarters · filed 2026-05-13 | |||||||||||
| 2025-12-31 | $46.00K 10-Q · filed 2026-02-17 | $56.00K 10-Q · filed 2026-02-17 | $139.00K derived: sum of 3 quarters · filed 2026-02-17 | $508.00K derived: sum of 4 quarters · filed 2026-05-13 | |||||||||||
| 2025-09-30 | $10.00K 10-Q · filed 2025-11-14 | $93.00K derived: sum of 2 quarters · filed 2025-11-14 | $462.00K derived: sum of 3 quarters · filed 2026-05-13 | $770.00K derived: sum of 4 quarters · filed 2026-05-13 | |||||||||||
| 2025-06-30 | $83.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-26 | $452.00K derived: sum of 2 quarters · filed 2026-05-13 | $760.00K derived: sum of 3 quarters · filed 2026-05-13 | $3.92M 10-K · filed 2025-09-26 | |||||||||||
| 2025-03-31 | $369.00K 10-Q · filed 2026-05-13 | $677.00K derived: sum of 2 quarters · filed 2026-05-13 | $3.84M 10-Q · filed 2026-05-13 | $7.78M derived: sum of 4 quarters · filed 2026-05-13 | |||||||||||
| 2024-12-31 | $308.00K 10-Q · filed 2026-02-17 | $3.47M 10-Q · filed 2026-02-17 | $7.42M derived: sum of 3 quarters · filed 2026-02-17 | $12.63M derived: sum of 4 quarters · filed 2026-02-17 | |||||||||||
| 2024-09-30 | $3.16M 10-Q · filed 2025-11-14 | $7.11M derived: sum of 2 quarters · filed 2025-11-14 | $12.33M derived: sum of 3 quarters · filed 2025-11-14 | $16.24M derived: sum of 4 quarters · filed 2025-11-14 | |||||||||||
| 2024-06-30 | $3.94M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-26 | $9.16M derived: sum of 2 quarters · filed 2025-09-26 | $13.08M derived: sum of 3 quarters · filed 2025-09-26 | $16.56M 10-K · filed 2025-09-26 | |||||||||||
| 2024-03-31 | $5.22M 10-Q · filed 2025-05-13 | $9.13M derived: sum of 2 quarters · filed 2025-05-13 | $12.62M 10-Q · filed 2025-05-13 | $15.19M derived: sum of 4 quarters · filed 2025-05-13 | |||||||||||
| 2023-12-31 | $3.91M 10-Q · filed 2025-02-12 | $7.40M 10-Q · filed 2025-02-12 | $9.97M derived: sum of 3 quarters · filed 2025-02-12 | $25.07M derived: sum of 4 quarters · filed 2025-02-12 | |||||||||||
| 2023-09-30 | $3.48M 10-Q · filed 2024-11-12 | $6.05M derived: sum of 2 quarters · filed 2024-11-12 | $21.16M derived: sum of 3 quarters · filed 2024-11-12 | $36.47M derived: sum of 4 quarters · filed 2024-11-12 | |||||||||||
| 2023-06-30 | $2.57M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-19 | $17.67M derived: sum of 2 quarters · filed 2024-09-19 | $32.99M derived: sum of 3 quarters · filed 2024-09-19 | $52.45M 10-K · filed 2024-09-19 | |||||||||||
| 2023-03-31 | $15.10M 10-Q · filed 2024-05-09 | $30.42M derived: sum of 2 quarters · filed 2024-05-09 | $49.88M 10-Q · filed 2024-05-09 | $71.72M derived: sum of 4 quarters · filed 2024-05-09 | |||||||||||
| 2022-12-31 | $15.31M 10-Q · filed 2024-02-13 | $34.78M 10-Q · filed 2024-02-13 | $56.62M derived: sum of 3 quarters · filed 2024-02-13 | $78.93M derived: sum of 4 quarters · filed 2024-02-13 | |||||||||||
| 2022-09-30 | $19.46M 10-Q · filed 2023-11-09 | $41.30M derived: sum of 2 quarters · filed 2023-11-09 | $63.62M derived: sum of 3 quarters · filed 2023-11-09 | $85.15M derived: sum of 4 quarters · filed 2023-11-09 | |||||||||||
| 2022-06-30 | $21.84M derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-26 | $44.16M derived: sum of 2 quarters · filed 2023-09-26 | $65.69M derived: sum of 3 quarters · filed 2023-09-26 | $85.64M 10-K · filed 2023-09-26 | |||||||||||
| 2022-03-31 | $22.32M 10-Q · filed 2023-05-11 | $43.85M derived: sum of 2 quarters · filed 2023-05-11 | $63.80M 10-Q · filed 2023-05-11 | $80.10M derived: sum of 4 quarters · filed 2023-05-11 | |||||||||||
| 2021-12-31 | $21.53M 10-Q · filed 2023-02-09 | $41.48M 10-Q · filed 2023-02-09 | $57.78M derived: sum of 3 quarters · filed 2023-02-09 | $75.66M derived: sum of 4 quarters · filed 2023-02-09 | |||||||||||
| 2021-09-30 | $19.95M 10-Q · filed 2022-11-14 | $36.25M derived: sum of 2 quarters · filed 2022-11-14 | $54.13M derived: sum of 3 quarters · filed 2022-11-14 | $76.36M derived: sum of 4 quarters · filed 2022-11-14 | |||||||||||
| 2021-06-30 | $16.29M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-08 | $34.18M derived: sum of 2 quarters · filed 2022-09-08 | $56.40M derived: sum of 3 quarters · filed 2022-09-08 | $69.40M 10-K · filed 2022-09-08 | |||||||||||
| 2021-03-31 | $17.88M 10-Q · filed 2022-05-23 | $40.11M derived: sum of 2 quarters · filed 2022-05-23 | $53.10M 10-Q · filed 2022-05-23 | $60.96M derived: sum of 4 quarters · filed 2022-09-08 | |||||||||||
| 2020-12-31 | $22.22M 10-Q/A · filed 2022-05-23 | $35.22M 10-Q/A · filed 2022-05-23 | $43.08M derived: sum of 3 quarters · filed 2022-09-08 | $52.04M derived: sum of 4 quarters · filed 2022-09-08 | |||||||||||
| 2020-09-30 | $13.00M 10-Q/A · filed 2022-05-23 | $20.86M derived: sum of 2 quarters · filed 2022-09-08 | $29.82M derived: sum of 3 quarters · filed 2022-09-08 | $38.10M derived: sum of 4 quarters · filed 2022-09-08 | |||||||||||
| 2020-06-30 | $7.86M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-08 | $16.82M derived: sum of 2 quarters · filed 2022-09-08 | $25.10M derived: sum of 3 quarters · filed 2022-09-08 | $34.06M 10-K · filed 2022-09-08 | |||||||||||
| 2020-03-31 | $8.96M 10-Q · filed 2021-05-06 | $17.24M derived: sum of 2 quarters · filed 2021-05-06 | $26.21M 10-Q · filed 2021-05-06 | $34.24M derived: sum of 4 quarters · filed 2022-05-23 | |||||||||||
| 2019-12-31 | $8.28M 10-Q · filed 2021-02-04 | $17.24M 10-Q · filed 2021-02-04 | $25.27M derived: sum of 3 quarters · filed 2022-05-23 | $34.35M derived: sum of 4 quarters · filed 2022-05-23 | |||||||||||
| 2019-09-30 | $8.96M 10-Q · filed 2020-11-10 | $16.99M derived: sum of 2 quarters · filed 2022-05-23 | $26.07M derived: sum of 3 quarters · filed 2022-05-23 | $35.13M derived: sum of 4 quarters · filed 2022-05-23 | |||||||||||
| 2019-06-30 | $8.03M derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-05-23 | $17.10M derived: sum of 2 quarters · filed 2022-05-23 | $26.17M derived: sum of 3 quarters · filed 2022-05-23 | $32.30M 10-K/A · filed 2022-05-23 | |||||||||||
| 2019-03-31 | $9.07M 10-Q · filed 2020-05-07 | $18.14M derived: sum of 2 quarters · filed 2020-05-07 | $24.27M 10-Q · filed 2020-05-07 | $28.73M derived: sum of 4 quarters · filed 2020-09-09 | |||||||||||
| 2018-12-31 | $9.07M 10-Q · filed 2020-02-06 | $15.20M 10-Q · filed 2020-02-06 | $19.66M derived: sum of 3 quarters · filed 2020-09-09 | $22.73M derived: sum of 4 quarters · filed 2020-09-09 | |||||||||||
| 2018-09-30 | $6.13M 10-Q · filed 2019-11-07 | $10.59M derived: sum of 2 quarters · filed 2020-09-09 | $13.66M derived: sum of 3 quarters · filed 2020-09-09 | $17.11M derived: sum of 4 quarters · filed 2020-09-09 | |||||||||||
| 2018-06-30 | $4.46M derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-09 | $7.53M derived: sum of 2 quarters · filed 2020-09-09 | $10.97M derived: sum of 3 quarters · filed 2020-09-09 | $17.04M 10-K · filed 2020-09-09 | |||||||||||
| 2018-03-31 | $3.07M 10-Q · filed 2019-05-09 | $6.51M derived: sum of 2 quarters · filed 2019-05-09 | $12.58M 10-Q · filed 2019-05-09 | $14.65M derived: sum of 4 quarters · filed 2019-08-28 | |||||||||||
| 2017-12-31 | $3.44M 10-Q · filed 2019-02-07 | $9.51M 10-Q · filed 2019-02-07 | $11.58M derived: sum of 3 quarters · filed 2019-08-28 | $13.46M derived: sum of 4 quarters · filed 2019-08-28 | |||||||||||
| 2017-09-30 | $6.06M 10-Q · filed 2018-11-08 | $8.14M derived: sum of 2 quarters · filed 2019-08-28 | $10.01M derived: sum of 3 quarters · filed 2019-08-28 | $11.65M derived: sum of 4 quarters · filed 2019-08-28 | |||||||||||
| 2017-06-30 | $2.07M derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-28 | $3.95M derived: sum of 2 quarters · filed 2019-08-28 | $5.59M derived: sum of 3 quarters · filed 2019-08-28 | $7.24M 10-K · filed 2019-08-28 | |||||||||||
| 2017-03-31 | $1.88M 10-Q · filed 2018-05-09 | $3.52M derived: sum of 2 quarters · filed 2018-05-09 | $5.16M 10-Q · filed 2018-05-09 | $9.15M derived: sum of 4 quarters · filed 2018-08-30 | |||||||||||
| 2016-12-31 | $1.64M 10-Q · filed 2018-02-08 | $3.29M 10-Q · filed 2018-02-08 | $7.27M derived: sum of 3 quarters · filed 2018-08-30 | $10.69M derived: sum of 4 quarters · filed 2018-08-30 | |||||||||||
| 2016-09-30 | $1.65M 10-Q · filed 2017-11-08 | $5.63M derived: sum of 2 quarters · filed 2018-08-30 | $9.05M derived: sum of 3 quarters · filed 2018-08-30 | $12.23M derived: sum of 4 quarters · filed 2018-08-30 | |||||||||||
| 2016-06-30 | $3.98M derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-30 | $7.41M derived: sum of 2 quarters · filed 2018-08-30 | $10.59M derived: sum of 3 quarters · filed 2018-08-30 | $13.40M 10-K · filed 2018-08-30 | |||||||||||
| 2016-03-31 | $3.42M 10-Q · filed 2017-05-04 | $6.60M derived: sum of 2 quarters · filed 2017-05-04 | $9.42M 10-Q · filed 2017-05-04 | $13.20M derived: sum of 4 quarters · filed 2017-09-05 | |||||||||||
| 2015-12-31 | $3.18M 10-Q · filed 2017-02-08 | $6.00M 10-Q · filed 2017-02-08 | $9.78M derived: sum of 3 quarters · filed 2017-09-05 | $16.55M derived: sum of 4 quarters · filed 2017-09-05 | |||||||||||
| 2015-09-30 | $2.82M 10-Q · filed 2016-11-09 | $6.59M derived: sum of 2 quarters · filed 2017-09-05 | $13.37M derived: sum of 3 quarters · filed 2017-09-05 | $20.07M derived: sum of 4 quarters · filed 2017-09-05 | |||||||||||
| 2015-06-30 | $3.78M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-05 | $10.55M derived: sum of 2 quarters · filed 2017-09-05 | $17.26M derived: sum of 3 quarters · filed 2017-09-05 | $23.82M 10-K · filed 2017-09-05 | |||||||||||
| 2015-03-31 | $6.78M 10-Q · filed 2016-05-05 | $13.48M derived: sum of 2 quarters · filed 2016-05-05 | $20.04M 10-Q · filed 2016-05-05 | $26.46M derived: sum of 4 quarters · filed 2016-09-06 | |||||||||||
| 2014-12-31 | $6.70M 10-Q · filed 2016-02-05 | $13.27M 10-Q · filed 2016-02-05 | $19.68M derived: sum of 3 quarters · filed 2016-09-06 | $25.10M derived: sum of 4 quarters · filed 2016-09-06 | |||||||||||
| 2014-09-30 | $6.57M 10-Q · filed 2015-11-06 | $12.98M derived: sum of 2 quarters · filed 2016-09-06 | $18.39M derived: sum of 3 quarters · filed 2016-09-06 | $22.79M derived: sum of 4 quarters · filed 2016-09-06 | |||||||||||
| 2014-06-30 | $6.41M derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-06 | $11.83M derived: sum of 2 quarters · filed 2016-09-06 | $16.23M derived: sum of 3 quarters · filed 2016-09-06 | $19.33M 10-K · filed 2016-09-06 | |||||||||||
| 2014-03-31 | $5.42M 10-Q · filed 2015-05-07 | $9.81M derived: sum of 2 quarters · filed 2015-05-07 | $12.92M 10-Q · filed 2015-05-07 | $14.57M derived: sum of 4 quarters · filed 2015-09-02 | $63.11M 10-Q · filed 2014-05-08 | ||||||||||
| 2013-12-31 | $4.40M 10-Q · filed 2015-02-06 | $7.50M 10-Q · filed 2015-02-06 | $9.15M derived: sum of 3 quarters · filed 2015-09-02 | $10.70M derived: sum of 4 quarters · filed 2015-09-02 | $57.69M 10-Q · filed 2014-02-11 | ||||||||||
| 2013-09-30 | $3.10M 10-Q · filed 2014-11-06 | $4.75M derived: sum of 2 quarters · filed 2015-09-02 | $6.30M derived: sum of 3 quarters · filed 2015-09-02 | $7.63M derived: sum of 4 quarters · filed 2015-09-02 | $53.29M 10-Q · filed 2013-11-08 | ||||||||||
| 2013-06-30 | $1.65M derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-02 | $3.19M derived: sum of 2 quarters · filed 2015-09-02 | $4.53M derived: sum of 3 quarters · filed 2015-09-02 | $6.08M 10-K · filed 2015-09-02 | $50.19M 10-K · filed 2013-09-18 | ||||||||||
| 2013-03-31 | $1.54M 10-Q · filed 2014-05-08 | $2.88M derived: sum of 2 quarters · filed 2014-05-08 | $4.43M 10-Q · filed 2014-05-08 | $5.75M derived: sum of 4 quarters · filed 2014-09-09 | $48.54M 10-Q · filed 2013-05-09 | ||||||||||
| 2012-12-31 | $1.34M 10-Q · filed 2014-02-11 | $2.89M 10-Q · filed 2014-02-11 | $4.21M derived: sum of 3 quarters · filed 2014-09-09 | $5.70M derived: sum of 4 quarters · filed 2014-09-09 | $46.99M 10-Q · filed 2013-02-12 | ||||||||||
| 2012-09-30 | $1.55M 10-Q · filed 2013-11-08 | $2.87M derived: sum of 2 quarters · filed 2014-09-09 | $4.36M derived: sum of 3 quarters · filed 2014-09-09 | $5.42M derived: sum of 4 quarters · filed 2014-09-09 | $45.66M 10-Q · filed 2012-11-13 | ||||||||||
| 2012-06-30 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-09 | $2.81M derived: sum of 2 quarters · filed 2014-09-09 | $3.87M derived: sum of 3 quarters · filed 2014-09-09 | $4.92M 10-K · filed 2014-09-09 | $44.10M 10-K · filed 2012-09-18 | ||||||||||
| 2012-03-31 | $1.49M 10-Q · filed 2013-05-09 | $2.55M derived: sum of 2 quarters · filed 2013-05-09 | $3.60M 10-Q · filed 2013-05-09 | $3.98M derived: sum of 4 quarters · filed 2013-05-09 | $42.78M 10-Q · filed 2012-05-15 | ||||||||||
| 2011-12-31 | $1.06M 10-Q · filed 2012-02-09 | $2.10M 10-Q · filed 2013-02-12 | $2.49M derived: sum of 3 quarters · filed 2013-02-12 | $2.78M derived: sum of 4 quarters · filed 2013-02-12 | $41.29M 10-Q · filed 2012-02-09 | ||||||||||
| 2011-09-30 | $1.04M 10-Q · filed 2012-11-13 | $1.43M derived: sum of 2 quarters · filed 2012-11-13 | $1.72M derived: sum of 3 quarters · filed 2012-11-13 | $2.47M derived: sum of 4 quarters · filed 2012-11-13 | $40.23M 10-Q · filed 2011-11-14 | ||||||||||
| 2011-06-30 | $381.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-09-18 | $679.00K derived: sum of 2 quarters · filed 2012-09-18 | $1.43M derived: sum of 3 quarters · filed 2012-09-18 | $2.12M 10-K · filed 2012-09-18 | |||||||||||
| 2011-03-31 | $298.00K 10-Q · filed 2012-05-15 | $1.05M derived: sum of 2 quarters · filed 2012-05-15 | $1.73M 10-Q · filed 2012-05-15 | ||||||||||||
| 2010-12-31 | $751.00K 10-Q · filed 2012-02-09 | $1.44M 10-Q · filed 2012-02-09 | |||||||||||||
| 2010-09-30 | $685.00K 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |